相似文献
1
Abnormal mitochondrial dynamics--a novel therapeutic target for Alzheimer's disease?
Mol Neurobiol. 2010 Jun;41(2-3):87-96. doi: 10.1007/s12035-009-8095-7. Epub 2010 Jan 27.
2
The role of abnormal mitochondrial dynamics in the pathogenesis of Alzheimer's disease.
J Neurochem. 2009 May;109 Suppl 1(Suppl 1):153-9. doi: 10.1111/j.1471-4159.2009.05867.x.
3
Abnormal mitochondrial dynamics in the pathogenesis of Alzheimer's disease.
J Alzheimers Dis. 2013;33 Suppl 1(0 1):S253-62. doi: 10.3233/JAD-2012-129005.
4
Amyloid Beta and Phosphorylated Tau-Induced Defective Autophagy and Mitophagy in Alzheimer's Disease.
Cells. 2019 May 22;8(5):488. doi: 10.3390/cells8050488.
5
Mitochondria dysfunction in the pathogenesis of Alzheimer's disease: recent advances.
Mol Neurodegener. 2020 May 29;15(1):30. doi: 10.1186/s13024-020-00376-6.
6
Inhibition of ERK-DLP1 signaling and mitochondrial division alleviates mitochondrial dysfunction in Alzheimer's disease cybrid cell.
Biochim Biophys Acta. 2014 Feb;1842(2):220-31. doi: 10.1016/j.bbadis.2013.11.009. Epub 2013 Nov 16.
7
Tau accumulation causes mitochondrial distribution deficits in neurons in a mouse model of tauopathy and in human Alzheimer's disease brain.
Am J Pathol. 2011 Oct;179(4):2071-82. doi: 10.1016/j.ajpath.2011.07.004. Epub 2011 Aug 18.
8
Unraveling APOE4's Role in Alzheimer's Disease: Pathologies and Therapeutic Strategies.
Curr Protein Pept Sci. 2025;26(4):259-281. doi: 10.2174/0113892037326839241014054430.
9
Mitochondrial dysfunction and Alzheimer's disease.
Prog Neuropsychopharmacol Biol Psychiatry. 2011 Mar 30;35(2):320-30. doi: 10.1016/j.pnpbp.2010.07.004. Epub 2010 Jul 16.
10
Recent Advances in Molecular Pathways and Therapeutic Implications Targeting Mitochondrial Dysfunction for Alzheimer's Disease.
Mol Neurobiol. 2022 Jan;59(1):535-555. doi: 10.1007/s12035-021-02612-6. Epub 2021 Nov 2.
引用本文的文献
1
Mitochondrial Fragmentation as a Key Driver of Neurodegenerative Disease.
Curr Alzheimer Res. 2024;21(9):607-614. doi: 10.2174/0115672050366194250107050650.
2
MFN2 suppresses clear cell renal cell carcinoma progression by modulating mitochondria-dependent dephosphorylation of EGFR.
Cancer Commun (Lond). 2023 Jul;43(7):808-833. doi: 10.1002/cac2.12428. Epub 2023 Jun 28.
3
Mitochondria in health, disease, and aging.
Physiol Rev. 2023 Oct 1;103(4):2349-2422. doi: 10.1152/physrev.00058.2021. Epub 2023 Apr 6.
4
Mitoprotective Effects of a Synergistic Nutraceutical Combination: Basis for a Prevention Strategy Against Alzheimer's Disease.
Front Aging Neurosci. 2022 Feb 21;13:781468. doi: 10.3389/fnagi.2021.781468. eCollection 2021.
5
Mechanisms associated with the dysregulation of mitochondrial function due to lead exposure and possible implications on the development of Alzheimer's disease.
Biometals. 2022 Feb;35(1):1-25. doi: 10.1007/s10534-021-00360-7. Epub 2022 Jan 20.
6
Dynamic Interplay between Copper Toxicity and Mitochondrial Dysfunction in Alzheimer's Disease.
Life (Basel). 2021 Apr 24;11(5):386. doi: 10.3390/life11050386.
7
Mitochondrial Dynamics Imbalance: A Strategy for Promoting Viral Infection.
Front Microbiol. 2020 Aug 21;11:1992. doi: 10.3389/fmicb.2020.01992. eCollection 2020.
8
Characterization and Discovery of a Selective Small-Molecule Modulator of Mitochondrial Complex I Targeting a Unique Binding Site.
J Med Chem. 2020 Oct 22;63(20):11819-11830. doi: 10.1021/acs.jmedchem.0c01021. Epub 2020 Oct 2.
9
Alzheimer's Disease is Driven by Intraneuronally Retained Beta-Amyloid Produced in the AD-Specific, βAPP-Independent Pathway: Current Perspective and Experimental Models for Tomorrow.
Ann Integr Mol Med. 2020;2(1):90-114. doi: 10.33597/aimm.02-1007.
10
AD "Statin": Alzheimer's Disorder is a "Fast" Disease Preventable by Therapeutic Intervention Initiated Even Late in Life and Reversible at the Early Stages.
Ann Integr Mol Med. 2020;2(1):75-89. doi: 10.33597/aimm.02-1006.
本文引用的文献
1
Presenilins are enriched in endoplasmic reticulum membranes associated with mitochondria.
Am J Pathol. 2009 Nov;175(5):1810-6. doi: 10.2353/ajpath.2009.090219. Epub 2009 Oct 15.
2
Abnormal mitochondrial dynamics and neurodegenerative diseases.
Biochim Biophys Acta. 2010 Jan;1802(1):135-42. doi: 10.1016/j.bbadis.2009.09.013. Epub 2009 Sep 30.
3
Impaired balance of mitochondrial fission and fusion in Alzheimer's disease.
J Neurosci. 2009 Jul 15;29(28):9090-103. doi: 10.1523/JNEUROSCI.1357-09.2009.
4
Mitochondrial fission factor Drp1 is essential for embryonic development and synapse formation in mice.
Nat Cell Biol. 2009 Aug;11(8):958-66. doi: 10.1038/ncb1907. Epub 2009 Jul 5.
5
Inhibition of mitochondrial fission favours mutant over wild-type mitochondrial DNA.
Hum Mol Genet. 2009 Sep 15;18(18):3407-16. doi: 10.1093/hmg/ddp281. Epub 2009 Jun 27.
6
PGC-1{alpha} and PGC-1{beta} regulate mitochondrial density in neurons.
J Biol Chem. 2009 Aug 7;284(32):21379-85. doi: 10.1074/jbc.M109.018911. Epub 2009 Jun 19.
7
Differential effects of PINK1 nonsense and missense mutations on mitochondrial function and morphology.
Exp Neurol. 2009 Sep;219(1):266-73. doi: 10.1016/j.expneurol.2009.05.027. Epub 2009 Jun 3.
8
Mitofusins and OPA1 mediate sequential steps in mitochondrial membrane fusion.
Mol Biol Cell. 2009 Aug;20(15):3525-32. doi: 10.1091/mbc.e09-03-0252. Epub 2009 May 28.
9
Caspase-cleaved tau expression induces mitochondrial dysfunction in immortalized cortical neurons: implications for the pathogenesis of Alzheimer disease.
J Biol Chem. 2009 Jul 10;284(28):18754-66. doi: 10.1074/jbc.M808908200. Epub 2009 Apr 23.
10
Amyloid beta, mitochondrial structural and functional dynamics in Alzheimer's disease.
Exp Neurol. 2009 Aug;218(2):286-92. doi: 10.1016/j.expneurol.2009.03.042. Epub 2009 Apr 7.
Zotero 插件